文献速递药物不良反应与药物警戒

基于ICD-10识别流程提高药物不良反应相关住院报告:瑞士多中心研究

Increasing the reporting of adverse drug reaction-related hospitalizations using an ICD-10-based identification workflow: A multicentre study from Switzerland.
PubMed 文献 · Br J Clin Pharmacol · 2026-05-05

该回顾性观察研究利用ADR指示性ICD-10编码筛查瑞士四家医院入院病例,识别可疑药物并将确认病例的个例安全性报告发送至Swissmedic。研究期间报告200例ADR相关住院,而参与医院既往每年约报告18例,筛查每例中位1分钟,收集编译发送确认病例数据中位8分钟。

要点

  • 基于ICD-10编码的筛查流程可显著增加ADR相关住院的报告数量
  • 多数ICR数据以结构化格式可得,缩短报告时间
  • 抗肿瘤药、精神抑制药和阿片类/其他镇痛药是主要致病药物类别

核心结论

  • 该流程成功增加了严重ADR的报告。

研究设计与样本

  • 回顾性观察研究,利用ADR指示性ICD-10编码筛查瑞士四家医院的入院病例,识别可疑药物并将确认病例的个例安全性报告发送至Swissmedic。

主要发现

  • 研究期间(2023年7月至12月)审查814例预筛入院后报告200例ADR相关住院。
  • 患者中位年龄59岁(IQR 42-75),87例(44%)为男性,中位合并症数为2(IQR 1-3)。
  • 最常见ADR为「K52.1中毒性胃肠炎和结肠炎」11例(6%)、「T42.4苯二氮卓类中毒」10例(5%)和「R11恶心和呕吐」10例(5%)。
  • 超过半数ADR相关住院由抗肿瘤药45例(23%)、精神抑制药38例(19%)、阿片类和其他镇痛药34例(17%)引起。
  • 筛查每例中位时间1分钟,收集编译发送确认病例数据中位时间8分钟。

临床怎么用

  • 可采用基于ICD-10编码的筛查流程识别ADR相关住院并提高报告率。
  • 利用结构化数据和大型语言模型从出院报告中识别可疑药物,可减少报告时间投入。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under-reporting remains widespread. We tested a novel method to increase reporting of ADR-related hospitalizations. METHODS: This retrospective observational study used ADR-indicative ICD-10 codes to screen admissions to four Swiss hospitals, identify suspected drugs and send individual case safety reports (ICSRs) of confirmed cases to Swissmedic. RESULTS: Participating hospitals previously reported ~18 ICSRs annually. During the study period (7/2023-12/2023), 200 ADR-related hospitalizations were reported following a review of 814 pre-filtered admissions. Most ICSR data were available in structured format: Median age of patients was 59 (interquartile range [IQR] 42-75); 87 (44%) males; median of two comorbidities (IQR 1-3); the three most frequent ADRs were 'K52.1 Toxic gastroenteritis and colitis' (11 [6%]), 'T42.4 Poisoning by benzodiazepines' (10 [5%]) and 'R11 Nausea and vomiting' (10 [5%]). Discharge reports contained free-text information on suspected drugs: More than half of ADR-related hospitalizations were caused by antineoplastics (45 [23%]), psycholeptics (38 [19%]), opioids and other analgesics (34 [17%]). The median time to screen a case was 1 min, 8 min to collect, compile and send data of confirmed cases. CONCLUSION: The approach successfully increased reporting of serious ADRs. The time investment for creating ICSRs might soon be rendered obsolete, as most data are available in structured format, and large language models are key to identifying suspected drugs in discharge reports.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Weber GA, Bartel SC, Boch M, et al. Increasing the reporting of adverse drug reaction-related hospitalizations using an ICD-10-based identification workflow: A multicentre study from Switzerland. Br J Clin Pharmacol. 2026. PMID: 42087456. doi:10.1002/bcp.70564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。